Ultragenyx Pharmaceutical shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $1.9M | 56k | 33.39 |
| 2026-03-31 | $119k | 5.7k | 20.95 |
| 2025-12-31 | $137k | 6.0k | 23.00 |
| 2025-09-30 | $173k | 5.8k | 30.08 |
| 2025-06-30 | $203k | 5.6k | 36.36 |
| 2025-03-31 | $198k | 5.5k | 36.21 |
| 2024-12-31 | $230k | 5.5k | 42.07 |
| 2024-09-30 | $316k | 5.7k | 55.55 |
| 2024-06-30 | $231k | 5.6k | 41.10 |
| 2023-12-31 | $228k | 4.8k | 47.82 |
| 2023-09-30 | $148k | 4.2k | 35.65 |
| 2023-06-30 | $192k | 4.2k | 46.13 |
| 2023-03-31 | $139k | 3.5k | 40.10 |
| 2022-12-31 | $160k | 3.4k | 46.33 |
| 2022-09-30 | $146k | 3.5k | 41.41 |
| 2022-06-30 | $211k | 3.5k | 59.66 |
| 2022-03-31 | $252k | 3.5k | 72.69 |
| 2021-09-30 | $30k | 328 | 91.46 |
| 2021-03-31 | $2.7M | 24k | 113.86 |
| 2020-12-31 | $3.4M | 25k | 138.43 |
| 2020-09-30 | $2.0M | 24k | 82.18 |
| 2020-06-30 | $2.0M | 25k | 78.22 |
| 2020-03-31 | $1.0M | 23k | 44.43 |
| 2019-12-31 | $1.0M | 25k | 42.71 |
| 2019-09-30 | $1.0M | 25k | 42.78 |
| 2019-06-30 | $1.4M | 22k | 63.50 |
| 2019-03-31 | $1.5M | 22k | 69.36 |
| 2018-12-31 | $879k | 20k | 43.46 |
| 2018-09-30 | $2.4M | 32k | 76.35 |
| 2018-06-30 | $1.7M | 22k | 76.87 |
| 2018-03-31 | $1.0M | 20k | 50.99 |
| 2017-12-31 | $849k | 18k | 46.36 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors